Medi-Cal prior authorization would start in May for six companies refusing to pay added rebates.
Executive Summary
MEDI-CAL FORMULARY REVIEW FOR PRIOR AUTHORIZATION RESTRICTIONS is to be completed no later than early May, Medi-Cal said. The state Medicaid agency is reviewing its formulary for products from six companies that have refused to pay manufacturer rebates. When Medi-Cal instituted a 10% supplemental manufacturer rebate program in July as a cost-saving measure, six companies refused to pay the rebate: DuPont Merck, Hoechst-Roussel, Pfizer, Sandoz, SmithKline Beecham, and Wyeth-Ayerst.